Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms-Reference-Cited by-同舟云学术

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms

Published:2018-01-16 Issue:5 Volume:168 Page:317
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Hultcrantz Malin¹,Björkholm Magnus²,Dickman Paul W.³,Landgren Ola⁴,Derolf Åsa R.²,Kristinsson Sigurdur Y.⁵,Andersson Therese M.L.³

Affiliation:

1. Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, and Memorial Sloan Kettering Cancer Center, New York, New York (M.H.)

2. Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden (M.B., Å.R.D.)

3. Karolinska Institutet, Stockholm, Sweden (P.W.D., T.M.A.)

4. Memorial Sloan Kettering Cancer Center, New York, New York (O.L.)

5. Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, and University of Iceland and Landspítali National University Hospital, Reykjavik, Iceland (S.Y.K.)

Funder

Swedish Blood Cancer Foundation

Radiumhemmets Forskningsfonder

The regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet

Adolf H Lundin Charitable Foundation

Memorial Sloan-Kettering Cancer Center

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms;Blood Advances;2024-08-14

2. Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: a systematic review and meta-analysis;Journal of Thrombosis and Haemostasis;2024-08

3. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24

4. The evolving landscape of polycythemia vera therapies;Expert Opinion on Pharmacotherapy;2024-07-23

5. The efficacy of erythrocyte apheresis for treatment of secondary erythrocytosis: An observational study;Medicine;2024-07-19